Coronary disease & ACSCohort study
1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions
- Registry-based cohort study
- nationwide registry
- multivariable adjusted
Authors' conclusion
Stentless PCI with DCB was frequently used in patients undergoing PCI for bypass graft lesions in Japan and was not associated with a significant difference in 1-year clinical outcomes compared with contemporary DES-based PCI strategies.
Study context
- Population
- Patients undergoing percutaneous coronary intervention (PCI) for bypass graft lesions, J-PCI OUTCOME registry, Japan, 2017–2020
- Participants
- 610 PCIs
- Exposure
- Drug-coated balloon (DCB)-only vs drug-eluting stent (DES) PCI for bypass graft lesions
- DCB-onlyn = 184
- Outcome
- MACE:
- All-cause death
- ACS
- Stroke
- Follow-up
- Within 1 year after PCI
Main finding
1-year MACE · 1 year
Adjusted hazard ratio
1.01
95% CI 0.58–1.76
P = 0.96
By group
DCB-only vs DES
adjusted HR 1.01 (95% CI 0.58–1.76); P = 0.96
As reported in the abstract
Observational data: associations, not effects.
Secondary outcomes
Individual MACE components, major bleeding, planned repeat revascularization
- No statistically significant differences
Original publication
1-Year Outcomes of Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent for Coronary Artery Bypass Graft Lesions. JACC Cardiovasc Interv. Published 31 August 2026. doi:10.1016/j.jcin.2026.06.023
Summarised from the published abstract; every number is checked against it